REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inmunopat S.A. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Inmunopat S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Inmunopat S.A. is a company based in Ecuador, with its head office in Guayaquil. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was first established on May 05, 2011. 4 (2024) employees currently work for Inmunopat S.A.. From the latest financial highlights, Inmunopat S.A. reported a net sales revenue drop of 14.39% in 2024. Its’ total assets recorded a growth of 5.19%. The net profit margin of Inmunopat S.A. decreased by 8.97% in 2024.

Headquarters
G 607, J-1 Bldg. , Floor 3
Guayaquil; Guayas;

Contact Details: Purchase the Inmunopat S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Inmunopat S.A. report to view the information.
Registered Capital:
Purchase the Inmunopat S.A. report to view the information.
Financial Auditors:
Purchase the Inmunopat S.A. report to view the information.
Incorporation Date:
May 05, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Inmunopat S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.39%▼
Total operating revenue
-14.14%▼
Operating profit (EBIT)
-50.23%▼
EBITDA
-50.02%▼
Net Profit (Loss) for the Period
-51.33%▼
Total assets
5.19%▲
Total equity
23.9%▲
Operating Profit Margin (ROS)
-13.58%▼
Net Profit Margin
-8.97%▼
Return on Equity (ROE)
-29.85%▼
Quick Ratio
0.26%▲
Cash Ratio
0.24%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo